203 related articles for article (PubMed ID: 22148860)
1. Effects of the val(158)met catechol-O-methyltransferase gene polymorphism on olfactory processing in schizophrenia.
Kamath V; Moberg PJ; Gur RE; Doty RL; Turetsky BI
Behav Neurosci; 2012 Feb; 126(1):209-215. PubMed ID: 22148860
[TBL] [Abstract][Full Text] [Related]
2. The association between the Val158Met polymorphism of the catechol-O-methyl transferase gene and morphological abnormalities of the brain in chronic schizophrenia.
Ohnishi T; Hashimoto R; Mori T; Nemoto K; Moriguchi Y; Iida H; Noguchi H; Nakabayashi T; Hori H; Ohmori M; Tsukue R; Anami K; Hirabayashi N; Harada S; Arima K; Saitoh O; Kunugi H
Brain; 2006 Feb; 129(Pt 2):399-410. PubMed ID: 16330500
[TBL] [Abstract][Full Text] [Related]
3. COMT val158met polymorphism and molecular alterations in the human dorsolateral prefrontal cortex: Differences in controls and in schizophrenia.
Shukla AA; Jha M; Birchfield T; Mukherjee S; Gleason K; Abdisalaam S; Asaithamby A; Adams-Huet B; Tamminga CA; Ghose S
Schizophr Res; 2016 May; 173(1-2):94-100. PubMed ID: 27021555
[TBL] [Abstract][Full Text] [Related]
4. Differential effects of the catechol-O-methyltransferase Val158Met genotype on the cognitive function of schizophrenia patients and healthy Japanese individuals.
Tsuchimine S; Yasui-Furukori N; Kaneda A; Kaneko S
PLoS One; 2013; 8(11):e76763. PubMed ID: 24282499
[TBL] [Abstract][Full Text] [Related]
5. Interaction between catechol-O-methyltransferase (COMT) Val158Met genotype and genetic vulnerability to schizophrenia during explicit processing of aversive facial stimuli.
Lo Bianco L; Blasi G; Taurisano P; Di Giorgio A; Ferrante F; Ursini G; Fazio L; Gelao B; Romano R; Papazacharias A; Caforio G; Sinibaldi L; Popolizio T; Bellantuono C; Bertolino A
Psychol Med; 2013 Feb; 43(2):279-92. PubMed ID: 22617427
[TBL] [Abstract][Full Text] [Related]
6. Interaction Between Val158Met Catechol-O-Methyltransferase Polymorphism and Social Cognitive Functioning in Schizophrenia: Pilot Study.
Tylec A; Jeleniewicz W; Mortimer A; Bednarska-Makaruk M; Kucharska K
Ann Hum Genet; 2017 Nov; 81(6):267-275. PubMed ID: 28856668
[TBL] [Abstract][Full Text] [Related]
7. [COMT Val158Met polymorphism and schizophrenia in a series of Spanish patients].
Díez-Martín J; Hoenicka J; Martínez I; Aragüés M; Rodríguez-Jiménez R; Jiménez-Arriero MA; Ponce G; Rubio G; Palomo T;
Med Clin (Barc); 2007 Jan; 128(2):41-4. PubMed ID: 17266899
[TBL] [Abstract][Full Text] [Related]
8. Temperament and character in remitted and symptomatic patients with schizophrenia: modulation by the COMT Val158Met genotype.
Hori H; Fujii T; Yamamoto N; Teraishi T; Ota M; Matsuo J; Kinoshita Y; Ishida I; Hattori K; Okazaki M; Arima K; Kunugi H
J Psychiatr Res; 2014 Sep; 56():82-9. PubMed ID: 24888672
[TBL] [Abstract][Full Text] [Related]
9. Association of catechol-O-methyltransferase Val(108/158) Met genetic polymorphism with schizophrenia, P50 sensory gating, and negative symptoms in a Chinese population.
Mao Q; Tan YL; Luo XG; Tian L; Wang ZR; Tan SP; Chen S; Yang GG; An HM; Yang FD; Zhang XY
Psychiatry Res; 2016 Aug; 242():271-276. PubMed ID: 27315458
[TBL] [Abstract][Full Text] [Related]
10. Opposite effects of catechol-O-methyltransferase Val158Met on cortical function in healthy subjects and patients with schizophrenia.
Prata DP; Mechelli A; Fu CH; Picchioni M; Kane F; Kalidindi S; McDonald C; Howes O; Kravariti E; Demjaha A; Toulopoulou T; Diforti M; Murray RM; Collier DA; McGuire PK
Biol Psychiatry; 2009 Mar; 65(6):473-80. PubMed ID: 19054502
[TBL] [Abstract][Full Text] [Related]
11. Catechol-O-methyltransferase Val 158 Met polymorphism and antisaccade eye movements in schizophrenia.
Haraldsson HM; Ettinger U; Magnusdottir BB; Sigmundsson T; Sigurdsson E; Ingason A; Petursson H
Schizophr Bull; 2010 Jan; 36(1):157-64. PubMed ID: 18562342
[TBL] [Abstract][Full Text] [Related]
12. The influence of the COMT genotype in the underlying functional brain activity of context processing in schizophrenia and in relatives.
Lopez-Garcia P; Cristobal-Huerta A; Young Espinoza L; Molero P; Ortuño Sanchez-Pedreño F; Hernández-Tamames JA
Prog Neuropsychopharmacol Biol Psychiatry; 2016 Nov; 71():176-82. PubMed ID: 27421706
[TBL] [Abstract][Full Text] [Related]
13. Genetic association of catechol-O-methyltransferase val(158)met polymorphism in Saudi schizophrenia patients.
Al-Asmary S; Kadasah S; Arfin M; Tariq M; Al-Asmari A
Genet Mol Res; 2014 Apr; 13(2):3079-88. PubMed ID: 24782165
[TBL] [Abstract][Full Text] [Related]
14. Catechol-O-Methyltransferase Val158Met Polymorphism and Clinical Response to Antipsychotic Treatment in Schizophrenia and Schizo-Affective Disorder Patients: a Meta-Analysis.
Huang E; Zai CC; Lisoway A; Maciukiewicz M; Felsky D; Tiwari AK; Bishop JR; Ikeda M; Molero P; Ortuno F; Porcelli S; Samochowiec J; Mierzejewski P; Gao S; Crespo-Facorro B; Pelayo-Terán JM; Kaur H; Kukreti R; Meltzer HY; Lieberman JA; Potkin SG; Müller DJ; Kennedy JL
Int J Neuropsychopharmacol; 2016 May; 19(5):. PubMed ID: 26745992
[TBL] [Abstract][Full Text] [Related]
15. Catechol-O-methyltransferase (COMT) genotype moderates the effects of childhood trauma on cognition and symptoms in schizophrenia.
Green MJ; Chia TY; Cairns MJ; Wu J; Tooney PA; Scott RJ; Carr VJ;
J Psychiatr Res; 2014 Feb; 49():43-50. PubMed ID: 24252819
[TBL] [Abstract][Full Text] [Related]
16. Replication study implicates COMT val158met polymorphism as a modulator of probabilistic reward learning.
Lancaster TM; Heerey EA; Mantripragada K; Linden DE
Genes Brain Behav; 2015 Jul; 14(6):486-92. PubMed ID: 26096878
[TBL] [Abstract][Full Text] [Related]
17. Epistasis between COMT Val158Met and DRD3 Ser9Gly polymorphisms and cognitive function in schizophrenia: genetic influence on dopamine transmission.
Loch AA; van de Bilt MT; Bio DS; Prado CM; de Sousa RT; Valiengo LL; Moreno RA; Zanetti MV; Gattaz WF
Braz J Psychiatry; 2015; 37(3):235-41. PubMed ID: 26376054
[TBL] [Abstract][Full Text] [Related]
18. Schizophrenia, cannabis use and Catechol-O-Methyltransferase (COMT): Modeling the interplay on cognition.
Bosia M; Buonocore M; Bechi M; Stere LM; Silvestri MP; Inguscio E; Spangaro M; Cocchi F; Bianchi L; Guglielmino C; Cavallaro R
Prog Neuropsychopharmacol Biol Psychiatry; 2019 Jun; 92():363-368. PubMed ID: 30790675
[TBL] [Abstract][Full Text] [Related]
19. Catechol-O-methyltransferase Val158Met genotype variation is associated with prefrontal-dependent task performance in schizotypal personality disorder patients and comparison groups.
Minzenberg MJ; Xu K; Mitropoulou V; Harvey PD; Finch T; Flory JD; New AS; Goldman D; Siever LJ
Psychiatr Genet; 2006 Jun; 16(3):117-24. PubMed ID: 16691129
[TBL] [Abstract][Full Text] [Related]
20. Catechol-O-methyltransferase Val158Met polymorphism influences prefrontal executive function in early Parkinson's disease.
Zhang Y; Feng S; Nie K; Zhao X; Gan R; Wang L; Zhao J; Tang H; Gao L; Zhu R; Wang L; Zhang Y
J Neurol Sci; 2016 Oct; 369():347-353. PubMed ID: 27653922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
